Skip to content

CA15-3 CLIA Microparticles

by Autobio Diagnostics Co., Ltd. 2 variants

Ref CMB0705, CMB0702Model AutoLumo analyzer

CA15-3 CLIA Microparticles (CMB0705) is an in vitro diagnostic device (EU IVDR Class C; EMDN category cancer antigen 15-3) made by Autobio Diagnostics Co., Ltd., registered in EUDAMED on 14 Sep 2024 (Basic UDI-DI 697015090000009H2), active as of 22 Oct 2026.

Active European Union

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number697015090000009H2 Basic UDI-DI Date14 Sep 2024RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Model / reference
AutoLumo analyzer, CMB0705, CMB0702
Primary DI / UDI-DI
06942359549318, 06970150908331
Basic UDI-DI
697015090000009H2
EMDN code
W0102030102 Cancer antigen 15-3
Device class
Class C
EU registration type
Standard device
EU market of registration
Italy

Manufacturer details

EUDAMED SRN
CN-MF-000003348
Authorised representative
QbD RepS BV BE-AR-000000040

Similar devices in this category

Other devices filed under CANCER ANTIGEN 15-3.

Other devices from Autobio Diagnostics Co., Ltd.

See all devices from Autobio Diagnostics Co., Ltd. →

Properties

  • Contains human tissues or cells
  • Contains animal tissues or cells
  • Reagent
  • IVD kit
  • Professional testing
  • New device YesEUDAMEDNoEUDAMED
Other properties (7, all answered No)